Delisting riskPopularity #4,794
Calidi Biotherapeutics (CLDI)
Develops systemic oncolytic-virus platforms that deliver therapeutic payloads into tumors.
$1.09
vs last close−0.02 (−1.80%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 7.13% | 32.9K shares | |
|---|---|---|---|
| 24 holders · as of Jun 30, 2026 | |||
| Other | 92.87% | 427.6K shares | |
| remainder | |||
460.4K company shares as of Aug 27, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Two share counts disagree (2.58M in the company's Sep 23, 2026 report, 460.4K elsewhere); stakes use the report.
13F, as of Jun 30, 2026
24 holders · 525.6K shares · 5 new positions · 12 increased · 0 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Geode Capital Management, LLC | 114.6K | 24.88% | +51.5K | Aug 12, 2026 |
| Hightower Advisors, LLC | 83.5K | 18.14% | 0 | Aug 5, 2026 |
| Jane Street Group, LLC | 54.3K | 11.79% | +19.5K | Aug 14, 2026 |
| Independent Advisor Alliance | 45.0K | 9.77% | +45.0Knew | Aug 12, 2026 |
| RS Crum Inc. | 43.2K | 9.39% | +3.0K | Aug 10, 2026 |
| SRS Capital Advisors, Inc. | 37.3K | 8.11% | 0 | Aug 10, 2026 |
| Private Advisor Group, LLC | 30.0K | 6.52% | +30.0Knew | Jul 27, 2026 |
| Vanguard Capital Management LLC | 25.5K | 5.54% | 0 | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Armistice Capital, LLC | 9.99% | 13G | May 15, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.